(3-(Piperidin-1-ylsulfonyl)phenyl)boronic acid, 98.0%, 1g

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 97.0%, 500mg

L-Gulose>98.0%(HPLC)25g

(Z)-(3)-Iodoacrylic acid, 95.0%, 5g

2-Mercaptopyridine>98.0%(HPLC)(T)100g

Culture plugs ROTILABO®, 16, Gesch. front, inside 16.5-18.0 mm, 15.5 mm 1000 pcs

2-((2R,3R,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl)acetamide, 98%, 250mg

1,1'-(Piperidine-1,4-diyl)bis(2,2,2-trifluoroethan-1-one), 98+%, 5g

1-(Benzo[b]thiophen-3-yl)ethan-1-one, 95+%, 1g

Tideglusib, 98.0%, 50mg

8-Methoxyquinazolin-4-ol, 95.0%, 10g

3-phenylpyridin-2-ylamine, 95.0%, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 97%, 250mg